Delivery Order SPE2DB24D1021-SPE2DB25FEXAF
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,801.80 for Trulicity 0.75 mg/0.5 ml pens on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication widely used in federal healthcare programs supporting military and veteran populations....
- The Defense Logistics Agency awarded a delivery order valued at $1,166.88 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 8, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare systems supported by the Defense...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,051.05 for Trulicity 0.75 mg/0.5 mL pens on August 15, 2025, with completion scheduled for August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and federal healthcare systems to support patient...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,000.54 for Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within military and federal healthcare systems, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $5,044.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and veteran healthcare systems supported...
- The Defense Logistics Agency awarded a $12,966.78 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on May 29, 2025, with completion required by May 30, 2025. This is a firm fixed-price, non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,201.20 for Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and federal healthcare systems. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,450.24 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on August 12, 2025, with completion scheduled for August 13, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare systems...
- The Defense Logistics Agency awarded a delivery order valued at $2,702.70 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEXAFDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,048.04 for Trulicity 0.75 mg/0.5 ml pens on May 22, 2025, with completion by May 23, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a branded diabetes medication commonly used in military and veteran healthcare settings. This delivery order represents a discrete transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 billion ceiling through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen maintains an established track record fulfilling federal medical procurement needs across multiple therapeutic domains through competitively awarded contracts with the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 5/22/25 |